Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Viatris (VTRS)
NASDAQ:VTRS
Holding VTRS?
Track your performance easily
VTRS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$8.45 - $13.34
Previous Close$11.24
Volume5.44M
Average Volume (3M)8.58M
Market Cap
$13.38B
Enterprise Value$30.34B
Total Cash (Recent Filing)$1.01B
Total Debt (Recent Filing)$17.97B
Price to Earnings (P/E)―
Beta0.98
Next Earnings
Aug 08, 2024EPS Estimate
$0.68Last Dividend Ex-Date
May 23, 2024Dividend Yield4.27%
Share Statistics
EPS (TTM)-0.05
Shares Outstanding1,190,675,819
10 Day Avg. Volume10,720,124
30 Day Avg. Volume8,576,528
Standard Deviation0.10
R-Squared0.25
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.62
Price to Sales (P/S)0.81
Price to Cash Flow (P/CF)5.10
P/FCF Ratio4.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.98
Enterprise Value/Gross Profit4.71
Enterprise Value/Ebitda13.81
Forecast
1Y Price Target
$11.00Price Target Upside0.00%
Rating ConsensusModerate Sell
Number of Analyst Covering2
Viatris News
PremiumCompany Announcements
Viatris Elects Directors and Amends Stock Plan at Meeting
PremiumCompany Announcements
Viatris Inc. Reports Strong Q3 2024 Performance
Ownership Overview
0.95% Insiders
23.79% Mutual Funds
30.66% Other Institutional Investors
44.60% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VTRS FAQ
What was Viatris’s price range in the past 12 months?
Viatris lowest stock price was $8.45 and its highest was $13.34 in the past 12 months.
What is Viatris’s market cap?
Currently, no data Available
When is Viatris’s upcoming earnings report date?
Viatris’s upcoming earnings report date is Aug 08, 2024 which is 136 days ago.
How were Viatris’s earnings last quarter?
Viatris released its earnings results on May 09, 2024. The company reported $0.67 earnings per share for the quarter, missing the consensus estimate of $0.673 by -$0.003.
Is Viatris overvalued?
According to Wall Street analysts Viatris’s price is currently same.
Does Viatris pay dividends?
Viatris pays a Quarterly dividend of $0.119 which represents an annual dividend yield of 4.27%. See more information on Viatris dividends here
What is Viatris’s EPS estimate?
Viatris’s EPS estimate is $0.68.
How many shares outstanding does Viatris have?
Viatris has 1,190,675,800 shares outstanding.
What happened to Viatris’s price movement after its last earnings report?
Viatris reported an EPS of $0.67 in its last earnings report, missing expectations of $0.673. Following the earnings report the stock price went down -4.966%.
Which hedge fund is a major shareholder of Viatris?
Among the largest hedge funds holding Viatris’s share is Davis Selected Advisers. It holds Viatris’s shares valued at 686M.
---
Viatris Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$11.00 (0.00% )
$11.00 (0.00% )
Blogger Sentiment
Bullish
VTRS Sentiment 94%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 10.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 1.3%
Last 30 Days ▼ 1.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
14.77%
12-Months-Change
Fundamentals
Return on Equity
-0.27%
Trailing 12-Months
Asset Growth
-3.95%
Trailing 12-Months
Company Description
Viatris
Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.
---
VTRS Company Deck
---
VTRS Earnings Call
Q1 2024
0:00 / 0:00
---
VTRS Net sales Breakdown
63.69% Brands
36.31% Generics
---
VTRS Stock 12 Month Forecast
Average Price Target
$11.00
▲(0.00% Upside)
Technical Analysis
Best Analysts Covering VTRS
1 Year
1 Year Success Rate
8/22 ratings generated profit
1 Year Average Return
-7.99%
reiterated a sell rating 6 months ago
Copying Jason Gerberry's trades and holding each position for 1 Year would result in 36.36% of your transactions generating a profit, with an average return of -7.99% per trade.
---